Clinical trial
Induction Treatment in Patients With Squamous Cell Carcinoma (SCC) of the Head and Neck Region Consisting Concomitant Chemotherapy and Low-dose Ionizing Radiotherapy
NCT05992610 is registered in ClinicalTrials.gov with Maria Sklodowska-Curie National Research Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induction Treatment in Patients With Squamous Cell Carcinoma (SCC) of the Head and Neck Region Consisting Concomitant Chemotherapy and Low-dose Ionizing Radiotherapy
- Lead sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 17, 2022
- Completion date
- March 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
larynx carcinoma, paranasal sinus carcinoma, pharynx carcinoma, squamous cell carcinoma of oral cavity